High-purity DSIP (Delta-Sleep-Inducing Peptide) represents a critical reference standard for laboratory research into central nervous system regulation, slow-wave sleep induction, and neuroendocrine homeostasis. Evaluated extensively across preclinical models, this nonapeptide offers researchers a stable tool for investigating hypothalamic-pituitary-adrenal axis dynamics and cellular recovery mechanisms.
High-purity DSIP (Delta-Sleep-Inducing Peptide) represents a critical reference standard for laboratory research into central nervous system regulation, slow-wave sleep induction, and neuroendocrine homeostasis. Evaluated extensively across preclinical models, this nonapeptide offers researchers a stable tool for investigating hypothalamic-pituitary-adrenal axis dynamics and cellular recovery mechanisms.
In analytical and preclinical literature, dsip-high-purity refers to Delta-Sleep-Inducing Peptide synthesized at sequence purities exceeding 98.0% as determined by Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) and mass spectrometry. This nonapeptide—comprising the amino acid sequence Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu—serves as a primary reference material for investigating slow-wave electroencephalographic (EEG) sleep architecture and neuroendocrine stress modulation.
First isolated from the cerebral venous blood of rabbits undergoing electrical delta-wave sleep stimulation, DSIP is an amphiphilic peptide with a molecular weight of approximately 848.81 Da. Maintaining high purity in research lots is essential because minor peptide fragments, counter-ion impurities, or bacterial endotoxins can significantly alter receptor binding kinetics, baseline neuronal firing rates, and downstream endocrine assays in controlled *in vitro* and *in vivo* studies.
Preclinical investigations demonstrate that high-purity DSIP exhibits unique neuromodulatory actions within the central nervous system. Unlike traditional sedative compounds that act primarily through global GABA-A receptor potentiation, high-purity DSIP appears to modulate endogenous circadian oscillator networks and deep slow-wave (delta) sleep patterns without disrupting normal physiological architecture.
In rodent and non-human primate models, central or peripheral administration of high-purity DSIP has been observed to increase spindle and delta-wave power during sleep cycles. *In vitro* microdialysis assays suggest this effect is mediated via complex interactions with central monoaminergic transmission, modulating serotonin turnover and attenuating hyper-reactive adrenergic pathways within the hypothalamus and brainstem.
Beyond its classical role in EEG delta-wave modulation, high-purity DSIP functions as a powerful regulator of the hypothalamic-pituitary-adrenal (HPA) axis under stressed baseline conditions. Preclinical research indicates that DSIP can suppress basal elevated levels of plasma corticotropin (ACTH) and corticosterone during acute thermal, physical, or psychological stress challenges.
By modulating stress-induced neuroendocrine cascades, high-purity DSIP protects cellular structures from oxidative burden during periods of systemic strain. *In vitro* neuronal cell culture assays show that application of DSIP attenuates stress-mediated membrane lipid peroxidation and maintains mitochondrial membrane potential under hypoxic or metabolic stress, making it a prominent candidate in broad cellular recovery research available across our all-peptides catalog.
When designing protocols to investigate neuroprotection, circadian dynamics, or stress response pathways, laboratory researchers frequently compare high-purity DSIP against other small regulatory peptides. While DSIP primarily targets slow-wave sleep dynamics and HPA-axis normalization, related compounds act through alternative target pathways within the central nervous system.
For example, researchers exploring circadian rhythms and telomeric stability often pair or contrast DSIP with Epitalon, a synthetic pineal tetrapeptide studied for its modulation of telomerase activity and melatonin secretion. Similarly, investigations focused on acute anxiety dynamics and neurotrophic factor expression frequently examine Selank or Semax, which exert pronounced effects on BDNF expression and enkephalin degradation rather than primary delta-wave induction. Exploring these comparative mechanisms in our research library helps refine experimental models.
Achieving reproducible experimental results requires rigid verification of chemical identity, purity, and freedom from manufacturing contaminants. PX1 Research subjects every lot of high-purity DSIP to rigorous analytical testing in independent ISO 17025 accredited laboratories located within the USA.
Analytical verification of DSIP includes double-column RP-HPLC to guarantee chemical purity of >= 98.0%, liquid chromatography-mass spectrometry (LC-MS) to confirm exact molecular weight and amino acid sequence fidelity, and Karl Fischer titration to measure residual moisture content. Residual trifluoroacetic acid (TFA) salts are meticulously monitored to ensure cell culture compatibility and eliminate ion interference in electrophysiological assays. Detailed lot-specific Certificate of Analysis (COA) documents are published for direct researcher verification.
Bacterial endotoxins (lipopolysaccharides) represent a primary confounding factor in *in vitro* cell assays and animal model research. High endotoxin levels trigger non-specific inflammatory cytokines, clouding readouts related to stress-axis regulation, delta-wave induction, or cellular viability.
PX1 Research enforces strict endotoxin screening protocols using kinetic chromogenic LAL (Limulus Amebocyte Lysate) testing under USP <85> guidelines. Every batch of high-purity DSIP must meet stringent research thresholds (<0.01 EU/mg), ensuring that experimental models measure genuine peptide activity free from immune system artifact. All compounds are synthesized in domestic, GMP-compliant facilities.
High-purity DSIP is supplied as a sterile, lyophilized white powder to maximize shelf-life and chemical stability. For downstream analytical or *in vitro* procedures, proper reconstitution protocols must be maintained in sterile laboratory conditions.
DSIP exhibits favorable solubility in aqueous buffers. Researchers typically reconstitute the lyophilized cake using sterile bacteriostatic water or phosphate-buffered saline (PBS, pH 7.4). Swirling the vial gently until full dissolution is recommended; mechanical vortexing should be avoided to prevent surface-induced peptide aggregation. For delicate bioassays sensitive to benzyl alcohol, sterile 0.9% sodium chloride solution is preferred.
Lyophilized high-purity DSIP maintains long-term stability when stored at -20°C or -80°C in a manual defrost freezer away from light. Under these desiccated conditions, the nonapeptide retains chemical integrity for extended periods without significant hydrolysis or racemization.
Once reconstituted into solution, DSIP aliquots should be used immediately or divided into single-use working volumes and stored at -80°C. Freeze-thaw cycles must be strictly minimized, as repeated temperature transitions accelerate peptide degradation and fragment formation. Review our detailed guide on delta sleep inducing peptide mechanisms for additional biochemical storage parameters.
PX1 Research provides high-purity DSIP to academic institutions, biotechnology research organizations, and analytical laboratories across North America. We provide full transparency with transparent lot traceability, batch COAs, and fast, reliable domestic fulfillment operating directly out of California and Arizona facilities with same-day shipping on weekday orders.
For large-scale screening studies, high-throughput assays, or institutional procurement, researchers can leverage our streamlined wholesale program. This portal provides dedicated account support and bulk volume pricing for qualified laboratory entities demanding verified purity standards.
What is the sequence and molecular weight of high-purity DSIP?
Delta-Sleep-Inducing Peptide (DSIP) is a synthetic nonapeptide with the primary amino acid sequence Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu and an exact molecular weight of 848.81 g/mol.
How is the purity of DSIP verified at PX1 Research?
PX1 Research verifies DSIP purity through third-party ISO 17025 accredited analytical testing using Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) to confirm >=98.0% purity and LC-MS to verify exact mass and sequence identity.
What preclinical models are used to research DSIP?
DSIP is primarily studied in rodent, feline, and non-human primate models, as well as neuronal cell cultures, to evaluate delta-wave sleep induction, HPA-axis stress modulation, and antioxidant enzyme activity.
What reconstituted solvents are recommended for DSIP laboratory assays?
Reconstitution is typically performed using sterile bacteriostatic water, 0.9% normal saline, or phosphate-buffered saline (PBS, pH 7.4), depending on the requirements of the specific cell culture or analytical protocol.
What are the endotoxin limits for PX1 Research high-purity DSIP?
Every lot of high-purity DSIP undergoes kinetic chromogenic LAL testing to ensure endotoxin levels remain strictly below <0.01 EU/mg, preventing non-specific inflammatory reactions in laboratory models.
How should high-purity DSIP be stored long-term?
Lyophilized DSIP should be stored desiccated at -20°C to -80°C. Reconstituted solutions should be divided into single-use aliquots and kept at -80°C to prevent freeze-thaw degradation.
Is high-purity DSIP approved for human use or clinical administration?
No. All compounds provided by PX1 Research, including high-purity DSIP, are strictly for laboratory research, *in vitro* testing, and preclinical experimentation. They are not for human or veterinary use.
Where does PX1 Research manufacture and ship its high-purity peptides?
PX1 Research compounds are synthesized in US-based GMP-compliant facilities and shipped directly from fulfillment centers in California and Arizona with same-day dispatch for orders placed Monday through Friday.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.